Advertisement
Monday, Nov 29, 2021
Outlook.com
Outlook.com

AstraZeneca's Covid-19 Vaccine Works On All Age Groups, 79% Effective: US Study

AstraZeneca on Monday said its Covid-19 vaccine had a 79 per cent efficacy rate at preventing symptomatic Covid and was 100 per cent effective in stopping severe disease

AstraZeneca's Covid-19 Vaccine Works On All Age Groups, 79% Effective: US Study
Representational Image | PTI
AstraZeneca's Covid-19 Vaccine Works On All Age Groups, 79% Effective: US Study
outlookindia.com
2021-03-23T16:50:53+05:30

AstraZeneca on Monday said advanced trial data from a U.S. study on its covid-19 vaccine shows it is 79 per cent effective.

Although AstraZeneca's vaccine has been authorised in more than 50 countries, it has not yet been given the green light in the US. The US study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announced Monday.

In a statement, AstraZeneca said its Covid-19 vaccine had a 79 per cent efficacy rate at preventing symptomatic Covid and was 100 per cent effective in stopping severe disease and hospitalisation. Investigators said the vaccine was effective across all ages, including older people — which previous studies in other countries had failed to establish.

The early findings from the US study are just one set of information AstraZeneca must submit to the Food and Drug Administration. An FDA advisory committee will publicly debate the evidence behind the shots before the agency decides whether to allow emergency use of the vaccine.

Scientists have been awaiting results of the US study in hopes it will clear up some of the confusion about just how well the shots really work.

Britain first authorized the vaccine based on partial results from testing in the United Kingdom, Brazil and South Africa that suggested the shots were about 70 per cent effective. But those results were clouded by a manufacturing mistake that led some participants to get just a half dose in their first shot — an error the researchers didn't immediately acknowledge.

Then came more questions, about how well the vaccine protected older adults and how long to wait before the second dose. Some European countries including Germany, France and Belgium initially withheld the shot from older adults and only reversed their decisions after new data suggested it is offering seniors protection.

Last week, more than a dozen countries, mostly in Europe, temporarily suspended their use of the AstraZeneca shot after reports it was linked to blood clots. On Thursday, the European Medicines Agency concluded after an investigation that the vaccine did not raise the overall risk of blood clots, but could not rule out that it was connected to two very rare types of clots.

France, Germany, Italy and other countries subsequently resumed their use of the shot on Friday, with senior politicians rolling up their sleeves to show the vaccine was safe.

Denmark was the first country to halt its use of the AstraZeneca Covid-19 vaccine, earlier this month after reports of blood clots in some people, including one person who developed multiple clots and died 10 days after receiving at least one dose.

Danish health authorities said the suspension would last for at least two weeks while the cases were investigated, even as they noted that “at present, it cannot be concluded whether there is a link between the vaccine and the blood clots.”

Norway, Iceland, Bulgaria, Thailand, and Congo had soon followed suit. 

Still, several other countries have stuck with the vaccine.

In response to the suspensions of its vaccine, AstraZeneca said it had carefully reviewed the data on 17 million people who received doses across Europe.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Heavy Fines, Media Gag: Maharashtra Learns From Past As It Gears To Tackle Omicron

Maharashtra CM Uddhav Thackeray has instructed all the ministers in charge of the districts to tighten coordination with the local administration to ensure proper prevention of another Covid-19 outbreak.

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

Omicron Shows Why Countries Need To Start Sharing Their Vaccines

'Despite the repeated warnings of health leaders, our failure to put vaccines into the arms of people in the developing world is now coming back to haunt us', wrote former British PM Gordon Brown.

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Iyer Plays Down Record, Says 'Important Thing Is To Win Match'

Shreyas Iyer hit 105 and 65 against New Zealand to become the first Indian batter to score a century and half-century in his debut Test match.

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Covid-19: Experts' Take On Omicron And Possibility Of Third Wave In India

Though the health experts and scientists in India have advised caution yet they feel that the current immune profile of the majority of the population in India makes them less vulnerable to Omicron as compared to any other country in the world.

Advertisement